Connect-Home: Alzheimer's Disease and Related Dementias
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Connect-Home ADRD.
- Who it may be relevant to
- Registry conditions: Alzheimer Disease, Dementia. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial
Overview
This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).
Detailed description
Connect-Home ADRD is a Donabedian-guided intervention that introduces new structure and processes to support Skilled Nursing Facility (SNF) staff delivery of transitional care for transitions to home, assisted living, or long-term care, and post-discharge transitional care by the Dementia Caregiving Specialist (DCS).
The research objective is to test the efficacy of Connect-Home ADRD, a transitional care intervention, targeting Skilled Nursing Facility (SNF) patients with Alzheimer's disease and related dementias (ADRD) and their primary caregivers who discharge home and other settings of care. The study will be set in 12 North Carolina SNFs and in the patient's discharge destination (during intervention periods only). Using a cluster-randomized trial design, twelve SNFs will be randomly allocated to an intervention group (N=6 SNFs) and to a control group (N=6 SNFs) by a study statistician masked to SNF identity. 360 dyads of SNF patients with ADRD and caregivers will be enrolled in 12 SNFs.
Interventions
- Behavioral Connect-Home ADRD
Connect-Home ADRD will introduce new structure and processes to support SNF staff delivery of transitional care for transitions to home, assisted living, or long-term care, and post-discharge transitional care by the Dementia Caregiving Specialist.
Primary outcome measures
- Caregiver Strain [Time frame: 30 days after discharge from SNF]
- Patient Neuropsychiatric Symptoms [Time frame: 30 days after discharge from SNF]
Secondary outcome measures (4)
- Caregiver Depression [Time frame: 30 days after discharge from SNF]
- Preparedness for care transitions [Time frame: 30 days after discharge from SNF]
- Patient Quality of Life [Time frame: 30 days after discharge from SNF]
- Acute Care Use [Time frame: 30 days after discharge from SNF]
Eligibility criteria
Inclusion criteria
Patients:
- Ability to speak English
- Goal of discharge to home, assisted living, or long-term care
- Diagnosis of dementia
- Having a caregiver willing to participate
Caregivers:
- Ability to speak English
- Legally authorized representative (LAR) who also provides support for the person with ADRD
Inclusion criteria for SNFs:
- Location within 120 miles of UNC-Chapel Hill
- Admission of at least 75 SNF patients per year
Exclusion criteria
Patients:
- Planned hospital readmission for procedures or treatments within 30 days post enrollment.
Caregivers:
- LAR is a court-appointed guardian.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- University of North Carolina at Chapel Hill — Chapel Hill
Identifiers
NCT: NCT06840587 · 24-2766 · 2R01NR017636-05A1